Form 8-K ARROWHEAD PHARMACEUTICAL For: Jun 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Arrowhead Pharmaceuticals appoints Dr. Matt Cohen to its board of directors
June 16, 2026 4:07 PM EDTArrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced that its Board of Directors appointed Dr. Matt Cohen, M.D., M.B.A., as a director of the company, effective June 12, 2026.
Dr. Cohen currently serves as Managing Director at Vida Ventures, a position he... More
